Phase 2 Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are aged between 18 and 75 years old
- People who have been diagnosed with esophageal squamous cell carcinoma (a specific type of esophageal cancer) confirmed by a tissue biopsy
- People whose cancer is located in the middle section of the esophagus and has been staged at a specific level using scans such as CT, MRI, or ultrasound (confirm with trial site for exact staging details)
- People who have at least one tumor that can be measured on a scan
- People who are generally well enough to carry out normal daily activities with little or no limitation (rated 0 or 1 on a standard health performance scale)
- People whose liver, kidneys, and other organs are functioning well enough to meet the trial's requirements
Who may not be able to join:
- People who have had another type of cancer within the past 5 years, unless it was a localised cancer that was fully treated and removed, such as certain skin cancers, early-stage bladder cancer, cervical pre-cancer, or breast cancer
- People whose cancer has clearly grown into nearby major structures such as the aorta (main heart artery) or windpipe, creating a higher risk of serious bleeding or a tear, or people who have already developed an abnormal connection (fistula) between the esophagus and nearby structures
- People who have already received any treatment for this cancer, including radiation therapy, chemotherapy, immunotherapy (such as interleukin, interferon, or thymus-related treatments), or traditional Chinese medicine treatments
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 138 0508 8816
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pathological complete response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.